Some of the treatments at the new center will be part of clinical trials. The Deep TMS Center will open in July, and will be the first of its kind.
Brainsway signed a distribution agreement with ATID last year, and received its first order in October.
Brainsway's share price rose 2% in morning trading to NIS 9.28, giving a market cap of NIS 389 million.
You comment was recieved and soon will be published.
Thank you for posting your comment, which will be reviewed for publication.
Load more comments